Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    16394300 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Intra-peritoneal Chemotherapy in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Immune Tolerance;   Neoplasms;   Effects of Chemotherapy
Intervention:
2 Recruiting Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
Conditions: Colorectal Cancer;   Appendix Cancer;   Peritoneal Carcinomatosis
Intervention: Drug: Oxaliplatin
3 Recruiting Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Interventions: Procedure: HIPEC;   Procedure: No HIPEC;   Drug: Paclitaxel;   Drug: carboplatin
4 Recruiting Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: Hyperthermic intraperitoneal chemotherapy (HIPEC);   Drug: Carboplatin
5 Active, not recruiting Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin
Condition: Ovarian Cancer
Intervention: Drug: Intraperitoneal cisplatin with nanocis
6 Recruiting Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer
Conditions: Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Procedure: Cytoreductive surgery;   Drug: IPEC with Cisplatin (75mg/m²);   Drug: IPEC with Cisplatin (120mg/m²);   Drug: Hypertherm IntraPEritoneal Chemotherapy with Cisplatin (75mg/m²);   Drug: HIPEC with Cisplatin (120mg/m²)
7 Recruiting Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma
Interventions: Drug: Paclitaxel(intravenous) + Carboplatin(intravenous);   Drug: Paclitaxel(intravenous) + Carboplatin(intraperitoneal)
8 Completed Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
Conditions: Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Drug: cisplatin;   Drug: paclitaxel;   Procedure: quality-of-life assessment

Indicates status has not been verified in more than two years